The Impact of Targeted Estrogen Receptor (ER) Imaging on Breast Cancer Patients
There is a new type of imaging that can offer unique insights to people with cancer that will allow physicians to choose a targeted treatment based on the characteristics of their cancer. It's called Molecular Imaging. Join Dr. Gary Ulaner, Director, Molecular Imaging and Therapy at the Hoag Family Cancer Institute.
Dr. Hannah Linden, Clinical Director of the Breast Cancer Program at the University of Washington/Fred Hutchinson Cancer Center.
Register to get instructions to join.
Wednesday, 3-4pm ET